OVARIAN ENDOMETRIOID CARCINOMA

This adverse event was reported 42 times

These drugs are most commonly taken by patients reporting OVARIAN ENDOMETRIOID CARCINOMA:

# Drug Count
0 TESTOSTERONE 9
1 CARBOPLATIN 6
2 LETROZOLE 6
3 LETROZOLE TABLETS 6
4 PACLITAXEL 6
5 PACLITAXEL (AIBUMIN-BOUND) 6
6 PALBOCICLIB 6
7 BEVACIZUMAB 3
8 GOLIMUMAB 3
9 BACLOFEN 2
See all common drugs associated with OVARIAN ENDOMETRIOID CARCINOMA

OVARIAN ENDOMETRIOID CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TESTOSTERONE UNDECANOATE 2 0.0010
1 FLURBIPROFEN 1 0.0007
2 TESTOSTERONE ENANTHATE 1 0.0006
3 MEGESTROL ACETATE 2 0.0005
4 TESTOSTERONE 9 0.0004
5 GOLIMUMAB 3 0.0002
6 LETROZOLE TABLETS 6 0.0001
7 LETROZOLE 6 0.0001
8 VITAMIN E 2 0.0001
9 PALBOCICLIB 6 0.0001
See all drugs enriched for association with OVARIAN ENDOMETRIOID CARCINOMA